The diabetes medicine sales in Türkiye have shown a consistent upward trend from 2023 to 2028. In 2023, the value stood at $21.0 US Dollars PPP Per Capita. Over the forecasted period, the year-on-year growth has been steady, with an increment of approximately 3.7% in 2024, 3.7% in 2025, 3.1% in 2026, 3.0% in 2027, and 3.3% in 2028. The Compound Annual Growth Rate (CAGR) for the period from 2023 to 2028 is around 3.4%, indicating a steady annual increase over the five-year period.
Future trends to watch for include advancements in diabetes treatment and management technologies, increasing awareness and early diagnosis of diabetes, and potential market dynamics driven by healthcare policies and economic shifts in Türkiye. Additionally, the increasing prevalence of diabetes might accelerate the demand and innovation in this sector, potentially impacting the market growth trajectory.
